Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Highlights

Highlights In This Issue December 2019 JAMA Otolaryngology– Volume 145, Number 12 Head & Neck Surgery Pages 65535-65535 Research Opinion Invited Commentary Risk Stratification for HPV-Associated OPSCC 1105 1158 The Challenges of Operating on the In this cohort study, Cramer et al assess the performance of the traditional pathologic risk Oldest Old—The Fountain of Youth stratification system for surgically resected human papillomavirus (HPV)–associated oro- Continues to Elude Head and Neck pharyngeal squamous cell carcinoma (OPSCC) and propose a novel composite risk stratifi- Reconstructive Surgeons SB Cannady and AE Kejner cation system. Using the National Cancer Database, the authors identified 15 324 patients diagnosed with nonmetastatic head and neck squamous cell carcinoma (HNSCC) who were 1167 Treatment of Head and Neck Cancer—Sometimes, Less Is More treated with upfront surgery and neck dissection. They compared traditional pathologic risk TJ Galloway and JA Ridge stratification for HPV+ OPSCC and HPV-unassociated HNSCC and derived a novel patho- 1178 Determining Operative Candidacy logic risk stratification system. and Avoiding Regret CT Haring and AG Shuman Machine Learning and Survival Predictors in OSCC 1115 Viewpoint In this cohort study including more than 30 000 patients, Karadaghy and colleagues de- 1101 The 2019 AHNS Annual Meeting scribe a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Highlights

Abstract

In This Issue December 2019 JAMA Otolaryngology– Volume 145, Number 12 Head & Neck Surgery Pages 65535-65535 Research Opinion Invited Commentary Risk Stratification for HPV-Associated OPSCC 1105 1158 The Challenges of Operating on the In this cohort study, Cramer et al assess the performance of the traditional pathologic risk Oldest Old—The Fountain of Youth stratification system for surgically resected human papillomavirus (HPV)–associated oro- Continues to Elude Head...
Loading next page...
 
/lp/american-medical-association/highlights-DMh8QuK0YG
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/jamaoto.2018.2813
Publisher site
See Article on Publisher Site

Abstract

In This Issue December 2019 JAMA Otolaryngology– Volume 145, Number 12 Head & Neck Surgery Pages 65535-65535 Research Opinion Invited Commentary Risk Stratification for HPV-Associated OPSCC 1105 1158 The Challenges of Operating on the In this cohort study, Cramer et al assess the performance of the traditional pathologic risk Oldest Old—The Fountain of Youth stratification system for surgically resected human papillomavirus (HPV)–associated oro- Continues to Elude Head and Neck pharyngeal squamous cell carcinoma (OPSCC) and propose a novel composite risk stratifi- Reconstructive Surgeons SB Cannady and AE Kejner cation system. Using the National Cancer Database, the authors identified 15 324 patients diagnosed with nonmetastatic head and neck squamous cell carcinoma (HNSCC) who were 1167 Treatment of Head and Neck Cancer—Sometimes, Less Is More treated with upfront surgery and neck dissection. They compared traditional pathologic risk TJ Galloway and JA Ridge stratification for HPV+ OPSCC and HPV-unassociated HNSCC and derived a novel patho- 1178 Determining Operative Candidacy logic risk stratification system. and Avoiding Regret CT Haring and AG Shuman Machine Learning and Survival Predictors in OSCC 1115 Viewpoint In this cohort study including more than 30 000 patients, Karadaghy and colleagues de- 1101 The 2019 AHNS Annual Meeting scribe a

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Dec 1, 2019

There are no references for this article.